
|Articles|January 19, 2016
ICON’s Flex Advantage IRT Platform
Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Advertisement
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Flex Advantage features:
- Randomization engine that can be adjusted mid-study or dynamically
- Plug-and-play modules for easier configuration
- Emergency unblinding support
- Enhanced reporting with customizable dashboard
- Integration with ICON products, such as ADDPLAN, Firecrest and ICONIK as well as external EDC, drug distributor and drug supply forecasting systems
Read the full
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
2
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
5




